Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
CELLTREAT Acquires VistaLab Technologies
CELLTREAT® Scientific Products (“CELLTREAT”) and VistaLab™ Technologies (“VistaLab”) today announced the execution of a definitive agreement under […]
Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care
Huma Therapeutics Limited, a global digital health technology company advancing digital-first care delivery and research […]
Elysium Health™ Announces Research Partnership with the University of Oxford for the Purpose of Developing Epigenetic Measures of Brain Aging and Health
Elysium Health, Inc.™, a leading life sciences company focused on aging research, has entered into […]
Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins
FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that FUJIFILM Irvine Scientific, […]
Transcenta Announces Global Clinical Collaboration with Bristol Myers Squibb to Evaluate TST001 in Combination with Opdivo® in Patients with Locally Advanced or Metastatic Gastric / Gastroesophageal Junction Cancer
Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in […]
Haemonetics Appoints James D'Arecca Chief Financial Officer
Haemonetics Corporation (NYSE: HAE) today announced that James C. D’Arecca will join the Company as Executive […]
Avacta Appoints Dr Christina Coughlin as Non-Executive Director
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and […]
David Thompson Joins OPEN Health as Chief Executive Officer for Evidence & Access
OPEN Health is pleased to announce the appointment of David Thompson, PhD, as Chief Executive Officer […]
New BHF Chief Technology Officer Appointed
British Heart Foundation are delighted to have appointed Alex Duncan as their new Chief Technology Officer (CTO). Alex, who is […]
New UK-wide Ambitions to Accelerate Genomic Research and Drive Innovation in Healthcare
Patients across the UK are set to benefit from faster cancer diagnosis and innovative new […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more